Skip to main content
Top
Published in: AIDS and Behavior 8/2011

01-11-2011 | Original Paper

A Comparison of the Efficacy of Two Interventions to Reduce HIV Risk Behaviors Among Drug Users

Authors: Clyde B. McCoy, Victor De Gruttola, Lisa Metsch, Mary Comerford

Published in: AIDS and Behavior | Issue 8/2011

Login to get access

Abstract

Numerous interventions have been developed and implemented to decrease risk behaviors which lead to HIV infection and transmission. These interventions have been differentially successful in reducing high risk behaviors in various populations. Testing and evaluation of the interventions have been subject to various degrees of rigor. The CDC recommends the use of interventions which have been rigorously tested and meet the standards for evidence based intervention rather than the continuation of the development of new interventions. Project RESPECT is an evidence based intervention that proved efficacious in increasing condom use among patients of STD clinics. We tested the efficacy of the RESPECT intervention against the NIDA standard intervention to determine if the RESPECT intervention was more effective in reducing high risk behaviors among drug users. Both interventions showed changes from baseline to follow-up; RESPECT was more effective than the NIDA standard intervention in reducing high risk sex behaviors.
Literature
1.
go back to reference Sogolow E, Peersnab G, Semaan S, Strouse D, Lyles C. The HIV/AIDS Prevention Research Synthesis Project: scope, methods, and study classification results. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S15–29.PubMed Sogolow E, Peersnab G, Semaan S, Strouse D, Lyles C. The HIV/AIDS Prevention Research Synthesis Project: scope, methods, and study classification results. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S15–29.PubMed
2.
go back to reference Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: finding from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–43.PubMedCrossRef Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: finding from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–43.PubMedCrossRef
3.
go back to reference Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lesions learned. AID Educ Prev. 2006;18(Suppl A):5–20.CrossRef Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lesions learned. AID Educ Prev. 2006;18(Suppl A):5–20.CrossRef
4.
go back to reference Dworkin SL, Pinto RM, Hunter J, Rapkin B, Remien RH. Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: critical reflections on the roll out of DEBI (Diffusion of Effective Behavioral Interventions). Am J Commun Psychol. 2008;42:51–9.CrossRef Dworkin SL, Pinto RM, Hunter J, Rapkin B, Remien RH. Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: critical reflections on the roll out of DEBI (Diffusion of Effective Behavioral Interventions). Am J Commun Psychol. 2008;42:51–9.CrossRef
6.
go back to reference Copenhaver M, Johnston B, Lee IC, Harman J, Carey M, Team TSR. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31:163–71.PubMedCrossRef Copenhaver M, Johnston B, Lee IC, Harman J, Carey M, Team TSR. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31:163–71.PubMedCrossRef
7.
go back to reference Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70:606–11.PubMedCrossRef Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70:606–11.PubMedCrossRef
8.
go back to reference Chitwood DD, Comerford M, Sanchez J. Prevalence and risk factors among sniffers, short-term injectors, and long term injectors of heroin. J Psychoact Drugs. 2003;35:445–53.CrossRef Chitwood DD, Comerford M, Sanchez J. Prevalence and risk factors among sniffers, short-term injectors, and long term injectors of heroin. J Psychoact Drugs. 2003;35:445–53.CrossRef
9.
go back to reference McCoy CB, Lai S, Metsch L, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14:535–42.PubMedCrossRef McCoy CB, Lai S, Metsch L, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14:535–42.PubMedCrossRef
10.
go back to reference Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161(10):1281–8.PubMedCrossRef Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161(10):1281–8.PubMedCrossRef
11.
go back to reference Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef
12.
go back to reference Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280:1161–7.PubMedCrossRef Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280:1161–7.PubMedCrossRef
13.
go back to reference National Institute on Drug Abuse. The standard intervention of the cooperative agreement program for AIDS community-based outreach/intervention research. Cooperative Agreement Steering Committee, January 9–10, 1992. National Institute on Drug Abuse. The standard intervention of the cooperative agreement program for AIDS community-based outreach/intervention research. Cooperative Agreement Steering Committee, January 9–10, 1992.
14.
go back to reference Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injection drug users: a review of published outcome data. Public Health Rep. 1998;113(Suppl 1):19–30.PubMed Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injection drug users: a review of published outcome data. Public Health Rep. 1998;113(Suppl 1):19–30.PubMed
15.
go back to reference Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.PubMedCrossRef Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.PubMedCrossRef
16.
go back to reference Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Social Probl. 1989;36:416–30.CrossRef Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Social Probl. 1989;36:416–30.CrossRef
17.
go back to reference Metsch LR, McCoy CB, Miles CC, Wohler B. Prevention myths and HIV risk reduction by active drug users. AIDS Educ Prev. 2004;16:150–9.PubMedCrossRef Metsch LR, McCoy CB, Miles CC, Wohler B. Prevention myths and HIV risk reduction by active drug users. AIDS Educ Prev. 2004;16:150–9.PubMedCrossRef
18.
go back to reference Chitwood DD, Inciardi JA, McBride DC, McCoy CB, McCoy HV, Trapido E. A community approach to AIDS intervention. New York: Greenwood Press; 1991. Chitwood DD, Inciardi JA, McBride DC, McCoy CB, McCoy HV, Trapido E. A community approach to AIDS intervention. New York: Greenwood Press; 1991.
19.
go back to reference Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980.
21.
go back to reference Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1897;1:39–44. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1897;1:39–44.
22.
go back to reference Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219–26.PubMedCrossRef Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219–26.PubMedCrossRef
23.
go back to reference Chitwood DD, McCoy CB, Comerford M, Kitner K. The prevalence and incidence of HIV among injection drug users: a five year panel study. Popul Res Policy Rev. 1999;18:39–53.CrossRef Chitwood DD, McCoy CB, Comerford M, Kitner K. The prevalence and incidence of HIV among injection drug users: a five year panel study. Popul Res Policy Rev. 1999;18:39–53.CrossRef
24.
go back to reference Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl J Med. 1989;321:874–9.PubMedCrossRef Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl J Med. 1989;321:874–9.PubMedCrossRef
25.
go back to reference Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women’s involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 1999;58:227–36.CrossRef Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women’s involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 1999;58:227–36.CrossRef
26.
go back to reference Wells EA, Calsyn DA, Saxon AJ, Greenberg DM. Using drugs to facilitate sexual behavior is associated with sexual variety among injection drug users. J Nerv Ment Dis. 1993;181:626–31.PubMedCrossRef Wells EA, Calsyn DA, Saxon AJ, Greenberg DM. Using drugs to facilitate sexual behavior is associated with sexual variety among injection drug users. J Nerv Ment Dis. 1993;181:626–31.PubMedCrossRef
27.
go back to reference Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200:1–26.PubMedCrossRef Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200:1–26.PubMedCrossRef
28.
go back to reference Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat Med. 2003;9:881–6.PubMedCrossRef Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat Med. 2003;9:881–6.PubMedCrossRef
29.
go back to reference Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(Suppl 1):97–106.PubMed Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(Suppl 1):97–106.PubMed
30.
go back to reference Friedmann PD, Lemon SC, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003;38:887–903.PubMedCrossRef Friedmann PD, Lemon SC, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003;38:887–903.PubMedCrossRef
31.
go back to reference Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51–71.PubMedCrossRef Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51–71.PubMedCrossRef
32.
go back to reference Alexander JA, Nahra TA, Wheeler JRC. Managed care and access to substance abuse treatment services. J Behav Health Serv Res. 2003;30:161–75.PubMedCrossRef Alexander JA, Nahra TA, Wheeler JRC. Managed care and access to substance abuse treatment services. J Behav Health Serv Res. 2003;30:161–75.PubMedCrossRef
33.
go back to reference Appel PW, Piculell R, Jansky HK, Griffy K. Assessing alcohol and other drug problems (AOD) among sexually transmitted disease (STD) clinic patients with a modified CAGE-A: Implications for AOD intervention services and STD prevention. Am J Drug Alcohol Abuse. 2006;32:129–53.CrossRef Appel PW, Piculell R, Jansky HK, Griffy K. Assessing alcohol and other drug problems (AOD) among sexually transmitted disease (STD) clinic patients with a modified CAGE-A: Implications for AOD intervention services and STD prevention. Am J Drug Alcohol Abuse. 2006;32:129–53.CrossRef
34.
go back to reference Tsiatis A, Davidian M, Zhang M, Lu X. Covariate adjustment for two-sample treatment comparisons for randomized clinical trials: a principled yet flexible approach. Stat Med. 2008;27:4658–67.PubMedCrossRef Tsiatis A, Davidian M, Zhang M, Lu X. Covariate adjustment for two-sample treatment comparisons for randomized clinical trials: a principled yet flexible approach. Stat Med. 2008;27:4658–67.PubMedCrossRef
35.
go back to reference Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89:846–66.CrossRef Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89:846–66.CrossRef
Metadata
Title
A Comparison of the Efficacy of Two Interventions to Reduce HIV Risk Behaviors Among Drug Users
Authors
Clyde B. McCoy
Victor De Gruttola
Lisa Metsch
Mary Comerford
Publication date
01-11-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-9975-1

Other articles of this Issue 8/2011

AIDS and Behavior 8/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.